Perrigo (PRGO) Financials

$10.94 -0.19 (-1.66%)

Closing price 05/13/2026 03:59 PM Eastern

Extended Trading

$10.96 +0.02 (+0.20%)

As of 07:31 AM Eastern

Annual Income Statements for Perrigo

This table shows Perrigo's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	6/27/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	136	-4,013	120	131	146	-163	-69	-141	-13	-172	-1,425
Consolidated Net Income / (Loss)	136	-4,013	120	131	146	-163	-69	-141	-13	-172	-1,425
Net Income / (Loss) Continuing Operations	136	-4,013	120	131	159	44	-131	-131	-4.40	-161	-1,402
Total Pre-Tax Income	260	-4,848	280	291	148	5.90	259	-139	-8.30	-81	-1,298
Total Operating Income	673	-2,000	598	237	175	265	410	79	152	113	-1,122
Total Gross Profit	1,644	2,052	1,980	1,832	1,434	1,495	1,416	1,455	1,680	1,543	1,495
Total Revenue	4,227	5,281	4,946	4,732	3,870	4,088	4,139	4,452	4,656	4,373	4,253
Operating Revenue	4,227	5,281	4,946	4,732	3,870	4,088	4,139	4,452	4,656	4,373	4,253
Total Cost of Revenue	2,583	3,229	2,967	2,900	2,436	2,593	2,723	2,996	2,975	2,831	2,759
Operating Cost of Revenue	2,583	3,229	2,967	2,900	2,436	2,593	2,723	2,996	2,975	2,831	2,759
Total Operating Expenses	972	4,052	1,381	1,595	1,259	1,230	1,006	1,377	1,529	1,430	2,617
Selling, General & Admin Expense	385	452	461	436	477	479	482	512	522	468	436
Marketing Expense	319	665	685	596	621	546	536	585	642	547	527
Research & Development Expense	188	184	168	219	119	122	122	123	123	112	95
Other Operating Expenses / (Income)	68	88	-41	99	2.90	81	-325	114	110	104	124
Impairment Charge	6.80	2,631	48	224	14	0.00	173	0.00	90	89	1,363
Restructuring Charge	5.10	31	61	21	26	3.20	17	43	42	110	72
Total Other Income / (Expense), net	-412	-2,849	-318	54	-27	-259	-152	-218	-160	-194	-176
Interest Expense	157	218	303	129	118	148	125	8.90	-3.20	6.70	0.00
Interest & Investment Income	-	-	-	-	-	-	-	-156	-174	-188	-163
Other Income / (Expense), net	-256	-2,631	-15	183	91	-112	-27	-53	10	0.90	-13
Income Tax Expense	124	-836	161	160	-11	-38	390	-8.20	-3.90	80	104
Net Income / (Loss) Discontinued Operations	-	-	-	-	-13	-207	62	-9.70	-8.30	-11	-23
Basic Earnings per Share	$0.97	($28.01)	$0.84	$0.95	$1.07	($1.20)	($0.52)	($1.04)	($0.09)	($1.25)	($10.29)
Weighted Average Basic Shares Outstanding	139.30M	143.30M	142.30M	137.80M	136M	136.10M	133.60M	134.50M	135.30M	137.40M	138.50M
Diluted Earnings per Share	$0.97	($28.01)	$0.84	$0.95	$1.07	($1.19)	($0.52)	($1.04)	($0.09)	($1.25)	($10.29)
Weighted Average Diluted Shares Outstanding	139.80M	143.30M	142.60M	138.30M	136.50M	137.20M	133.60M	134.50M	135.30M	137.40M	138.50M
Weighted Average Basic & Diluted Shares Outstanding	147.90M	143.30M	142.40M	140.90M	136.13M	133.10M	133.78M	134.65M	135.52M	136.46M	137.65M
Cash Dividends to Common per Share	$0.46	$0.58	$0.64	$0.76	$0.82	$0.90	$0.96	$1.04	$1.09	$1.10	$1.16

This table shows Perrigo's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/30/2024	6/29/2024	9/28/2024	12/31/2024	3/29/2025	6/28/2025	9/27/2025	12/31/2025	3/28/2026
Net Income / (Loss) Attributable to Common Shareholders	14	-32	2.00	-108	-21	-44	-6.40	-8.40	7.50	-1,418	-399
Consolidated Net Income / (Loss)	14	-32	2.00	-108	-21	-44	-6.40	-8.40	7.50	-1,418	-399
Net Income / (Loss) Continuing Operations	15	-28	4.10	-106	-18	-42	0.10	-0.50	13	-1,415	-390
Total Pre-Tax Income	19	-54	-99	-74	22	70	8.30	3.20	22	-1,332	-409
Total Operating Income	62	-16	-55	-27	80	114	47	45	73	-1,287	-372
Total Gross Profit	411	427	358	395	404	386	392	363	377	362	326
Total Revenue	1,124	1,157	1,082	1,066	1,088	1,138	1,044	1,056	1,043	1,110	969
Operating Revenue	1,124	1,157	1,082	1,066	1,088	1,138	1,044	1,056	1,043	1,110	969
Total Cost of Revenue	713	730	724	671	683	752	652	693	666	747	644
Operating Cost of Revenue	713	730	724	671	683	752	652	693	666	747	644
Total Operating Expenses	349	443	413	421	324	272	345	318	305	1,649	698
Selling, General & Admin Expense	126	129	130	126	117	95	112	113	94	117	115
Marketing Expense	150	153	150	150	129	92	146	137	152	92	130
Research & Development Expense	30	30	29	29	26	28	27	22	25	22	25
Other Operating Expenses / (Income)	28	25	59	45	19	6.40	28	36	13	47	23
Impairment Charge	0.00	-	0.00	34	16	-	3.10	1.50	0.00	1,359	331
Restructuring Charge	16	17	44	37	17	12	29	8.70	21	13	75
Total Other Income / (Expense), net	-43	-39	-43	-48	-59	-44	-39	-42	-50	-45	-36
Interest Expense	0.00	-	0.00	-	5.10	-	0.00	-	0.00	-	1.40
Interest & Investment Income	-44	-	-43	-44	-58	-	-39	-40	-41	-43	-41
Other Income / (Expense), net	0.60	0.60	-0.40	-3.40	4.10	0.60	0.40	-2.60	-9.60	-1.40	6.00
Income Tax Expense	3.80	-27	-103	32	39	112	8.20	3.70	9.70	83	-19
Net Income / (Loss) Discontinued Operations	-1.20	-4.70	-2.10	-2.70	-3.40	-2.90	-6.50	-7.90	-5.20	-3.50	-8.70
Basic Earnings per Share	$0.10	($0.23)	$0.01	($0.79)	($0.15)	($0.32)	($0.05)	($0.06)	$0.05	($10.23)	($2.87)
Weighted Average Basic Shares Outstanding	135.50M	135.30M	136.60M	137.10M	137.50M	137.40M	137.70M	138.20M	138.50M	138.50M	138.70M
Diluted Earnings per Share	$0.10	($0.23)	$0.01	($0.79)	($0.15)	($0.32)	($0.05)	($0.06)	$0.05	($10.23)	($2.87)
Weighted Average Diluted Shares Outstanding	136.90M	135.30M	137.60M	137.10M	137.50M	137.40M	137.70M	138.20M	138.90M	138.50M	138.70M
Weighted Average Basic & Diluted Shares Outstanding	135.51M	135.52M	136.32M	136.42M	136.43M	136.46M	137.48M	137.58M	137.62M	137.65M	138.37M
Cash Dividends to Common per Share	$0.27	-	$0.27	$0.27	$0.27	$0.29	$0.29	$0.29	$0.29	-	$0.29

This table details how cash moves in and out of Perrigo's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	6/27/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	-14	205	56	-128	-197	287	1,238	-1,279	151	-193	-25
Net Cash From Operating Activities	855	655	699	593	388	636	156	307	406	363	239
Net Cash From Continuing Operating Activities	855	655	699	568	388	961	156	307	406	363	239
Net Income / (Loss) Continuing Operations	136	-4,013	120	131	146	163	-69	-141	-13	-172	-1,425
Consolidated Net Income / (Loss)	136	-4,013	120	131	146	-163	-69	-141	-13	-172	-1,425
Depreciation Expense	259	457	445	424	397	385	312	339	360	326	338
Amortization Expense	0.20	-25	-22	-8.10	-4.40	-2.40	-3.80	-0.70	4.00	-1.20	-15
Non-Cash Adjustments To Reconcile Net Income	302	5,294	312	95	169	526	203	133	196	274	1,486
Changes in Operating Assets and Liabilities, net	158	-1,059	-156	16	-320	-110	-286	-23	-141	-64	-145
Net Cash From Investing Activities	-2,302	-175	2,338	-127	-596	-188	1,276	-1,959	-78	79	-75
Net Cash From Continuing Investing Activities	-2,302	-175	2,338	-127	-596	-188	1,276	-1,962	-97	74	-81
Purchase of Property, Plant & Equipment	-137	-106	-89	-138	-287	-206	-152	-96	-102	-118	-93
Acquisitions	-2,182	-493	-0.40	0.00	-748	-184	-71	-2,011	0.00	-13	-1.50
Purchase of Investments	-330	0.00	0.00	-7.50	-	-	-	62	0.00	-48	0.00
Divestitures	0.00	69	155	5.20	183	188	1,492	59	0.00	216	14
Sale and/or Maturity of Investments	0.00	4.50	2,200	-	-	0.00	0.00	-	-	-	0.00
Other Investing Activities, net	346	350	73	14	256	14	6.60	-	0.00	0.00	-0.50
Net Cash From Financing Activities	1,522	-269	-3,005	-572	1.80	-181	-179	422	-187	-611	-221
Net Cash From Continuing Financing Activities	1,522	-269	-3,005	-572	1.80	-181	-179	422	-187	-611	-221
Repayment of Debt	-1,925	-1,374	-2,732	-499	-487	-637	-49	-1,023	-314	-1,534	-42
Payment of Dividends	-65	-83	-91	-105	-112	-124	-130	-142	-150	-153	-159
Issuance of Debt	2,504	1,190	9.10	431	600	744	0.00	1,587	295	1,091	0.00
Other Financing Activities, net	-	-	-	-	-	-	-	-	-19	-16	-19
Cash Interest Paid	143	205	188	134	137	146	133	217	277	251	202
Cash Interest Received	1.10	1.20	9.30	5.00	15	12	8.00	58	101	75	60
Cash Income Taxes Paid	131	140	187	144	136	81	448	100	108	156	99

This table details how cash moves in and out of Perrigo's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/30/2024	6/29/2024	9/28/2024	12/31/2024	3/29/2025	6/28/2025	9/27/2025	12/31/2025	3/28/2026
Net Change in Cash & Equivalents	43	153	-93	-116	921	-905	-142	37	-20	100	-174
Net Cash From Operating Activities	125	209	-1.40	9.50	42	313	-65	76	52	175	-114
Net Cash From Continuing Operating Activities	134	209	-1.40	13	38	313	-65	76	52	175	-114
Net Income / (Loss) Continuing Operations	14	-32	2.00	-2.00	-127	-45	-6.40	-8.40	7.50	-1,418	-399
Consolidated Net Income / (Loss)	14	-32	2.00	-	-	-45	-6.40	-8.40	7.50	-1,418	-399
Depreciation Expense	91	86	81	82	82	80	80	86	85	86	83
Amortization Expense	0.40	0.50	0.40	0.30	0.40	7.80	-4.20	2.20	-16	-3.20	-2.70
Non-Cash Adjustments To Reconcile Net Income	40	116	60	-4.10	106	113	44	26	33	1,384	417
Changes in Operating Assets and Liabilities, net	-12	39	-145	-63	-23	156	-178	-30	-58	127	-212
Net Cash From Investing Activities	-31	-23	-24	-73	213	-37	-26	-3.80	-21	-25	-12
Net Cash From Continuing Investing Activities	-31	-43	-24	-73	213	-42	-26	-3.80	-21	-30	-12
Purchase of Property, Plant & Equipment	-32	-27	-25	-28	-27	-38	-26	-19	-22	-27	-14
Acquisitions	-	-	0.00	-	-	-	-1.50	-	-	-	0.00
Other Investing Activities, net	0.90	-	1.60	0.90	1.00	-	1.30	1.00	0.50	-3.30	1.40
Net Cash From Financing Activities	-43	-45	-60	-50	653	-1,154	-62	-54	-50	-54	-45
Net Cash From Continuing Financing Activities	-43	-45	-60	-50	653	-1,154	-62	-54	-50	-54	-45
Repayment of Debt	-4.40	-302	-23	-12	-402	-1,113	-9.30	-15	8.40	-14	-430
Payment of Dividends	-39	-38	-38	-38	-38	-40	-41	-39	-40	-40	-40
Issuance of Debt	-	295	-	-	-	-1.50	0.00	-	-	-	428
Other Financing Activities, net	-	-	-	-	-	-	-12	-	-	-0.30	-2.80
Effect of Exchange Rate Changes	-7.40	12	-7.50	-2.10	-	-	10	-	-	-	-3.10

This table presents Perrigo's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	19,350	13,870	11,629	10,983	11,301	11,488	10,426	11,017	10,809	9,648	8,535
Total Current Assets	2,792	2,805	2,820	2,902	2,731	3,134	3,860	2,720	2,833	2,482	2,797
Cash & Equivalents	418	622	679	551	354	632	1,865	-	-	559	532
Accounts Receivable	1,189	1,176	1,131	1,073	1,243	594	653	697	740	642	613
Inventories, net	899	795	807	878	967	1,059	1,020	1,150	1,141	1,082	1,149
Prepaid Expenses	286	212	203	400	166	182	306	272	201	199	231
Other Current Nonoperating Assets	-	-	-	-	-	667	16	-	-	0.00	273
Plant, Property, & Equipment, net	886	870	833	829	903	865	864	926	916	918	899
Total Noncurrent Assets	15,672	10,195	7,976	7,252	7,668	7,490	5,702	7,371	7,060	6,248	4,839
Goodwill	7,069	4,164	4,266	4,029	4,186	3,103	3,005	3,549	3,534	3,325	2,055
Intangible Assets	2,973	3,397	3,291	2,859	2,921	2,482	2,146	3,230	2,981	2,424	2,352
Noncurrent Deferred & Refundable Income Taxes	71	72	10	1.20	5.40	41	6.50	7.10	26	5.10	3.30
Other Noncurrent Operating Assets	5,558	2,562	410	363	556	502	544	585	519	494	430
Total Liabilities & Shareholders' Equity	19,350	13,870	11,629	10,983	11,301	11,488	10,426	11,017	10,809	9,648	8,535
Total Liabilities	9,243	7,913	5,458	5,315	5,497	5,833	5,274	6,175	6,041	5,328	5,600
Total Current Liabilities	2,552	1,836	1,436	1,537	1,336	1,382	1,588	1,114	1,586	1,044	1,013
Short-Term Debt	1,061	573	70	190	3.40	37	604	36	441	36	37
Accounts Payable	556	472	450	475	520	452	411	537	478	495	475
Accrued Expenses	748	644	651	644	624	312	405	389	499	372	342
Current Deferred & Payable Income Tax Liabilities	63	32	116	97	32	9.00	17	14	42	17	21
Current Employee Benefit Liabilities	125	116	149	132	156	153	119	136	127	123	112
Other Current Nonoperating Liabilities	-	-	-	-	-	420	33	-	-	0.00	27
Total Noncurrent Liabilities	6,691	6,076	4,022	3,778	4,162	4,451	3,686	5,062	4,455	4,284	4,587
Long-Term Debt	4,972	5,225	3,271	3,052	3,366	3,528	2,917	4,070	3,633	3,582	3,604
Noncurrent Deferred & Payable Income Tax Liabilities	1,373	390	322	282	281	276	239	368	262	203	169
Other Noncurrent Operating Liabilities	346	462	430	443	515	539	530	623	560	499	814
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	10,107	5,958	6,171	5,668	5,804	5,655	5,152	4,842	4,768	4,319	2,936
Total Preferred & Common Equity	10,107	5,958	6,171	5,668	5,804	5,655	5,152	4,842	4,768	4,319	2,936
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	10,107	5,958	6,171	5,668	5,804	5,655	5,152	4,842	4,768	4,319	2,936
Common Stock	8,143	8,135	7,893	7,422	7,360	7,118	7,043	6,937	6,838	6,734	6,608
Retained Earnings	1,980	-2,095	-1,976	-1,838	-1,696	-1,858	-1,927	-2,068	-2,080	-2,252	-3,678
Accumulated Other Comprehensive Income / (Loss)	-15	-82	253	85	139	395	36	-27	11	-162	4.80

This table presents Perrigo's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	10/1/2022	4/1/2023	7/1/2023	9/30/2023	3/30/2024	6/29/2024	9/28/2024	3/29/2025	6/28/2025	9/27/2025	3/28/2026
Total Assets	10,678	10,955	10,965	10,758	10,640	10,397	11,203	9,760	10,094	10,084	7,983
Total Current Assets	2,583	2,741	2,773	2,765	2,806	2,959	3,708	2,533	2,615	2,879	2,712
Cash & Equivalents	469	553	555	598	659	543	1,464	410	454	432	357
Accounts Receivable	708	739	754	738	780	726	786	717	678	644	697
Inventories, net	1,085	1,183	1,168	1,150	1,121	1,116	1,134	1,155	1,216	1,227	1,121
Prepaid Expenses	322	266	296	280	247	282	312	229	267	295	272
Other Current Nonoperating Assets	0.00	-	-	-	-	292	13	22	-	281	265
Plant, Property, & Equipment, net	840	919	918	903	911	910	909	913	914	903	878
Total Noncurrent Assets	7,254	7,295	7,273	7,090	6,923	6,528	6,586	6,314	6,565	6,302	4,393
Goodwill	3,492	3,650	3,658	3,555	3,498	3,375	3,427	3,381	3,485	3,366	1,706
Intangible Assets	3,003	3,084	3,031	2,941	2,870	2,634	2,655	2,457	2,558	2,400	2,259
Noncurrent Deferred & Refundable Income Taxes	7.70	6.10	6.30	6.80	28	14	22	5.40	48	64	4.70
Other Noncurrent Operating Assets	751	555	579	587	526	506	482	471	474	472	423
Total Liabilities & Shareholders' Equity	10,678	10,955	10,965	10,758	10,640	10,397	11,203	9,760	10,094	10,084	7,983
Total Liabilities	6,075	6,121	6,116	6,020	5,953	5,852	6,637	5,396	5,622	5,638	5,485
Total Current Liabilities	1,015	1,087	1,057	1,008	1,555	1,488	1,451	1,074	1,126	1,145	998
Short-Term Debt	34	39	38	38	441	441	441	36	36	37	11
Accounts Payable	461	505	471	433	454	472	459	502	489	470	435
Accrued Expenses	380	419	436	419	538	387	395	396	468	473	340
Current Deferred & Payable Income Tax Liabilities	22	18	7.60	9.80	7.70	12	10	14	10	5.90	29
Current Employee Benefit Liabilities	118	107	104	109	114	125	138	120	122	123	154
Other Current Nonoperating Liabilities	0.00	-	-	-	-	52	8.20	4.50	-	37	29
Total Noncurrent Liabilities	5,060	5,034	5,059	5,012	4,399	4,364	5,187	4,322	4,496	4,492	4,487
Long-Term Debt	4,078	4,063	4,056	4,049	3,625	3,617	4,313	3,591	3,616	3,608	3,621
Noncurrent Deferred & Payable Income Tax Liabilities	409	334	345	349	248	212	214	189	207	194	154
Other Noncurrent Operating Liabilities	573	638	659	614	526	535	660	542	673	690	712
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	4,603	4,834	4,849	4,738	4,687	4,545	4,566	4,364	4,472	4,447	2,499
Total Preferred & Common Equity	4,603	4,834	4,849	4,738	4,687	4,545	4,566	4,364	4,472	4,447	2,499
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	4,603	4,834	4,849	4,738	4,687	4,545	4,566	4,364	4,472	4,447	2,499
Common Stock	6,964	6,911	6,891	6,864	6,803	6,786	6,764	6,693	6,664	6,636	6,578
Retained Earnings	-2,044	-2,071	-2,062	-2,048	-2,078	-2,187	-2,208	-2,259	-2,267	-2,259	-4,076
Accumulated Other Comprehensive Income / (Loss)	-317	-6.30	20	-78	-38	-54	9.80	-70	75	70	-3.00

This table displays calculated financial ratios and metrics derived from Perrigo's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	6/27/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	8.00%	24.92%	-6.33%	-4.34%	-18.21%	5.64%	1.24%	7.56%	4.58%	-6.06%	-2.75%
EBITDA Growth	-13.48%	-721.33%	123.96%	-17.02%	-21.18%	-18.52%	29.12%	-47.45%	44.10%	-14.41%	-285.34%
EBIT Growth	-27.25%	-1,210.99%	112.60%	-28.16%	-36.60%	-42.19%	149.80%	-93.28%	529.07%	-29.88%	-1,097.72%
NOPAT Growth	-19.75%	-498.09%	118.25%	-58.26%	75.71%	960.56%	-110.45%	126.60%	92.52%	-25.67%	-1,093.98%
Net Income Growth	-41.54%	-3,048.42%	102.98%	9.53%	11.53%	-211.29%	57.63%	-104.06%	90.97%	-1,252.76%	-729.69%
EPS Growth	-51.74%	-2,987.63%	103.00%	13.10%	12.63%	-211.22%	56.30%	-100.00%	91.35%	-1,288.89%	-723.20%
Operating Cash Flow Growth	35.10%	-23.42%	6.72%	-15.15%	-34.60%	64.05%	-75.43%	96.61%	31.96%	-10.51%	-34.28%
Free Cash Flow Firm Growth	40.80%	175.19%	-19.88%	-77.29%	-146.92%	1,466.39%	-98.56%	-2,832.86%	124.81%	116.93%	0.57%
Invested Capital Growth	41.27%	-29.19%	-20.66%	-5.36%	5.50%	-19.66%	-3.69%	22.33%	-3.09%	-8.79%	-21.42%
Revenue Q/Q Growth	-9.15%	16.80%	-0.97%	-1.82%	-17.83%	20.58%	1.27%	1.14%	0.04%	-0.43%	-0.67%
EBITDA Q/Q Growth	-26.78%	-51.37%	235.75%	7.70%	-28.48%	-9.32%	15.99%	3.74%	-9.39%	41.43%	-238.40%
EBIT Q/Q Growth	-40.58%	-49.29%	149.69%	19.95%	-50.08%	-25.33%	46.90%	-34.85%	-20.36%	815.72%	-523.81%
NOPAT Q/Q Growth	-33.29%	-42.77%	912.68%	-33.85%	-2.66%	642.40%	67.93%	-16.51%	60.28%	772.02%	-902.44%
Net Income Q/Q Growth	-63.78%	-46.77%	109.11%	6.85%	-40.75%	-2,363.64%	72.82%	-31.03%	-209.76%	-7.58%	-2,657.06%
EPS Q/Q Growth	-65.48%	-47.19%	109.17%	10.47%	-41.21%	-2,280.00%	72.19%	-30.00%	-200.00%	-7.76%	-2,607.89%
Operating Cash Flow Q/Q Growth	0.66%	-4.60%	1.55%	-3.67%	-21.27%	3.40%	-58.00%	1,820.63%	5.96%	40.12%	-36.52%
Free Cash Flow Firm Q/Q Growth	0.00%	201.45%	-36.65%	-9.17%	-426.19%	705.75%	-95.57%	2.64%	328.92%	117.34%	122.88%
Invested Capital Q/Q Growth	44.76%	-14.52%	-1.40%	-1.43%	1.08%	-16.95%	2.30%	1.25%	-1.66%	-6.02%	-21.81%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	38.90%	38.86%	40.02%	38.71%	37.05%	36.57%	34.22%	32.69%	36.09%	35.27%	35.14%
EBITDA Margin	15.99%	-79.50%	20.33%	17.64%	17.00%	13.11%	16.72%	8.17%	11.26%	10.26%	-19.11%
Operating Margin	15.91%	-37.87%	12.09%	5.00%	4.51%	6.49%	9.92%	1.77%	3.26%	2.58%	-26.39%
EBIT Margin	9.86%	-87.69%	11.79%	8.86%	6.87%	3.76%	9.27%	0.58%	3.49%	2.60%	-26.70%
Profit (Net Income) Margin	3.22%	-75.99%	2.42%	2.77%	3.78%	-3.98%	-1.66%	-3.16%	-0.27%	-3.93%	-33.51%
Tax Burden Percent	52.29%	82.77%	42.70%	45.08%	98.72%	-2,755.93%	-26.63%	101.08%	153.01%	212.89%	109.82%
Interest Burden Percent	62.45%	104.70%	48.01%	69.34%	55.70%	3.84%	67.42%	-539.15%	-5.11%	-70.91%	114.31%
Effective Tax Rate	47.71%	0.00%	57.30%	54.92%	-7.23%	-649.15%	150.60%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	2.62%	-10.43%	2.56%	1.24%	2.18%	24.98%	-2.99%	0.73%	1.29%	1.02%	-11.92%
ROIC Less NNEP Spread (ROIC-NNEP)	-2.75%	-58.86%	-0.91%	2.15%	0.74%	-71.72%	5.96%	-6.84%	-2.19%	-6.84%	-33.53%
Return on Net Nonoperating Assets (RNNOA)	-1.17%	-39.53%	-0.59%	0.97%	0.37%	-27.82%	1.71%	-3.54%	-1.56%	-4.80%	-27.37%
Return on Equity (ROE)	1.45%	-49.96%	1.97%	2.21%	2.55%	-2.84%	-1.28%	-2.81%	-0.26%	-3.78%	-39.29%
Cash Return on Invested Capital (CROIC)	-31.59%	23.75%	25.59%	6.75%	-3.17%	46.78%	0.77%	-19.36%	4.43%	10.22%	12.06%
Operating Return on Assets (OROA)	2.51%	-27.88%	4.58%	3.71%	2.38%	1.35%	3.50%	0.24%	1.49%	1.11%	-12.49%
Return on Assets (ROA)	0.82%	-24.16%	0.94%	1.16%	1.31%	-1.43%	-0.63%	-1.31%	-0.12%	-1.68%	-15.68%
Return on Common Equity (ROCE)	1.45%	-49.96%	1.97%	2.21%	2.55%	-2.84%	-1.28%	-2.81%	-0.26%	-3.78%	-39.29%
Return on Equity Simple (ROE_SIMPLE)	1.35%	-67.35%	1.94%	2.31%	2.52%	-2.88%	-1.34%	-2.90%	-0.27%	-3.98%	0.00%
Net Operating Profit after Tax (NOPAT)	352	-1,400	255	107	187	1,987	-208	55	106	79	-786
NOPAT Margin	8.32%	-26.51%	5.16%	2.25%	4.84%	48.60%	-5.02%	1.24%	2.28%	1.81%	-18.47%
Net Nonoperating Expense Percent (NNEP)	5.37%	48.44%	3.47%	-0.91%	1.45%	96.70%	-8.94%	7.56%	3.49%	7.86%	21.61%
Return On Investment Capital (ROIC_SIMPLE)	2.18%	-11.91%	2.69%	1.20%	2.04%	21.55%	-2.39%	0.62%	1.20%	1.00%	-11.95%
Cost of Revenue to Revenue	61.10%	61.14%	59.98%	61.29%	62.95%	63.43%	65.78%	67.31%	63.91%	64.73%	64.86%
SG&A Expenses to Revenue	9.12%	8.56%	9.32%	9.21%	12.31%	11.70%	11.65%	11.51%	11.22%	10.70%	10.25%
R&D to Revenue	4.44%	3.48%	3.39%	4.62%	3.08%	2.98%	2.95%	2.77%	2.63%	2.57%	2.24%
Operating Expenses to Revenue	22.99%	76.72%	27.93%	33.71%	32.53%	30.08%	24.30%	30.92%	32.83%	32.69%	61.52%
Earnings before Interest and Taxes (EBIT)	417	-4,631	583	419	266	154	384	26	162	114	-1,135
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	676	-4,198	1,006	835	658	536	692	364	524	449	-813
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.27	1.66	1.66	0.78	1.04	0.94	0.90	0.87	0.87	0.79	0.64
Price to Tangible Book Value (P/TBV)	351.34	0.00	0.00	0.00	0.00	75.26	5,174.67	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	5.43	1.87	2.08	0.94	1.56	1.31	1.13	0.95	0.89	0.78	0.44
Price to Earnings (P/E)	168.57	0.00	85.82	33.95	41.37	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.29%	0.84%	0.88%	2.32%	1.85%	2.30%	2.76%	3.31%	3.56%	4.34%	8.33%
Earnings Yield	0.59%	0.00%	1.17%	2.95%	2.42%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.82	1.35	1.46	0.85	1.03	1.17	0.93	0.93	0.92	0.88	0.86
Enterprise Value to Revenue (EV/Rev)	6.76	2.85	2.61	1.51	2.34	2.02	1.53	1.74	1.60	1.48	1.17
Enterprise Value to EBITDA (EV/EBITDA)	42.26	0.00	12.85	8.55	13.77	15.43	9.12	21.27	14.21	14.46	0.00
Enterprise Value to EBIT (EV/EBIT)	68.51	0.00	22.16	17.03	34.10	53.84	16.45	299.80	45.88	56.99	0.00
Enterprise Value to NOPAT (EV/NOPAT)	81.21	0.00	50.61	66.96	48.36	4.16	0.00	140.05	70.03	82.07	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	33.39	23.01	18.50	12.04	23.36	13.00	40.39	25.17	18.36	17.87	20.89
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	4.73	5.06	12.30	0.00	2.22	117.47	0.00	20.44	8.21	6.27
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.60	0.97	0.54	0.57	0.58	0.63	0.68	0.85	0.85	0.84	1.24
Long-Term Debt to Equity	0.49	0.88	0.53	0.54	0.58	0.62	0.57	0.84	0.76	0.83	1.23
Financial Leverage	0.43	0.67	0.65	0.45	0.50	0.39	0.29	0.52	0.71	0.70	0.82
Leverage Ratio	1.76	2.07	2.10	1.91	1.94	1.99	2.03	2.15	2.27	2.25	2.51
Compound Leverage Factor	1.10	2.17	1.01	1.32	1.08	0.08	1.37	-11.57	-0.12	-1.60	2.87
Debt to Total Capital	37.38%	49.32%	35.13%	36.39%	36.73%	38.66%	40.60%	45.89%	46.07%	45.58%	55.36%
Short-Term Debt to Total Capital	6.57%	4.87%	0.74%	2.13%	0.04%	0.40%	6.96%	0.40%	4.98%	0.46%	0.56%
Long-Term Debt to Total Capital	30.81%	44.45%	34.39%	34.25%	36.69%	38.26%	33.63%	45.49%	41.09%	45.12%	54.80%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	62.63%	50.69%	64.87%	63.61%	63.27%	61.34%	59.40%	54.11%	53.93%	54.42%	44.64%
Debt to EBITDA	8.93	-1.38	3.32	3.89	5.12	6.65	5.09	11.29	7.77	8.07	-4.48
Net Debt to EBITDA	8.31	-1.23	2.65	3.22	4.58	5.47	2.39	9.64	6.34	6.82	-3.83
Long-Term Debt to EBITDA	7.36	-1.24	3.25	3.66	5.12	6.58	4.21	11.19	6.93	7.98	-4.43
Debt to NOPAT	17.16	-4.14	13.08	30.41	17.99	1.79	-16.95	74.35	38.31	45.78	-4.63
Net Debt to NOPAT	15.97	-3.70	10.42	25.24	16.09	1.48	-7.97	63.48	31.24	38.71	-3.96
Long-Term Debt to NOPAT	14.14	-3.73	12.81	28.63	17.97	1.78	-14.05	73.70	34.17	45.32	-4.59
Altman Z-Score	1.94	-0.10	1.62	0.97	1.02	0.91	1.05	0.73	0.76	0.73	-0.09
Noncontrolling Interest Sharing Ratio	0.00%	-0.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.09	1.53	1.96	1.89	2.04	2.27	2.43	2.44	1.79	2.38	2.76
Quick Ratio	0.63	0.98	1.26	1.06	1.20	0.89	1.59	0.63	0.47	0.62	1.13
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-4,241	3,189	2,555	580	-272	3,720	54	-1,469	364	790	795
Operating Cash Flow to CapEx	624.23%	616.67%	788.83%	429.09%	135.22%	309.44%	102.76%	433.43%	416.75%	451.37%	255.35%
Free Cash Flow to Firm to Interest Expense	-27.10	14.65	8.42	4.52	-2.31	25.19	0.43	-165.02	0.00	117.96	0.00
Operating Cash Flow to Interest Expense	5.46	3.01	2.30	4.61	3.29	4.31	1.25	34.53	0.00	54.16	0.00
Operating Cash Flow Less CapEx to Interest Expense	4.59	2.52	2.01	3.54	0.86	2.92	0.03	26.56	0.00	42.16	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.25	0.32	0.39	0.42	0.35	0.36	0.38	0.42	0.43	0.43	0.47
Accounts Receivable Turnover	3.99	4.47	4.29	4.29	3.34	4.45	6.64	6.60	6.48	6.33	6.78
Inventory Turnover	3.38	3.81	3.70	3.44	2.64	2.56	2.62	2.76	2.60	2.55	2.47
Fixed Asset Turnover	5.07	6.01	5.81	5.69	4.47	4.63	4.79	4.97	5.05	4.77	4.68
Accounts Payable Turnover	5.61	6.28	6.44	6.27	4.90	5.34	6.31	6.32	5.86	5.82	5.69
Days Sales Outstanding (DSO)	91.55	81.74	85.11	85.00	109.23	81.99	54.96	55.35	56.32	57.67	53.86
Days Inventory Outstanding (DIO)	108.01	95.73	98.54	106.03	138.23	142.63	139.40	132.21	140.54	143.30	147.58
Days Payable Outstanding (DPO)	65.01	58.08	56.71	58.21	74.54	68.39	57.84	57.77	62.26	62.72	64.15
Cash Conversion Cycle (CCC)	134.54	119.39	126.95	132.82	172.92	156.23	136.53	129.78	134.60	138.24	137.29
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	15,721	11,133	8,833	8,359	8,819	7,086	6,824	8,348	8,090	7,379	5,798
Invested Capital Turnover	0.31	0.39	0.50	0.55	0.45	0.51	0.60	0.59	0.57	0.57	0.65
Increase / (Decrease) in Invested Capital	4,593	-4,589	-2,300	-474	460	-1,734	-261	1,524	-258	-711	-1,580
Enterprise Value (EV)	28,556	15,071	12,927	7,139	9,060	8,269	6,313	7,735	7,446	6,486	4,983
Market Capitalization	22,943	9,896	10,264	4,448	6,045	5,336	4,657	4,229	4,124	3,427	1,874
Book Value per Share	$69.10	$41.56	$43.81	$41.72	$42.64	$41.43	$38.51	$35.96	$35.19	$31.66	$21.33
Tangible Book Value per Share	$0.45	($11.18)	($9.84)	($8.98)	($9.57)	$0.52	$0.01	($14.39)	($12.89)	($10.48)	($10.69)
Total Capital	16,139	11,755	9,512	8,911	9,173	9,220	8,672	8,949	8,841	7,938	6,576
Total Debt	6,032	5,797	3,341	3,242	3,369	3,565	3,521	4,107	4,073	3,618	3,640
Total Long-Term Debt	4,972	5,225	3,271	3,052	3,366	3,528	2,917	4,070	3,633	3,582	3,604
Net Debt	5,614	5,175	2,663	2,691	3,015	2,933	1,656	3,506	3,322	3,059	3,109
Capital Expenditures (CapEx)	137	106	89	138	287	206	152	71	97	80	93
Debt-free, Cash-free Net Working Capital (DFCFNWC)	882	920	775	1,004	1,044	1,157	1,011	1,042	936	915	1,290
Debt-free Net Working Capital (DFNWC)	1,300	1,542	1,454	1,555	1,398	1,789	2,876	1,643	1,687	1,474	1,821
Net Working Capital (NWC)	239	969	1,384	1,365	1,395	1,752	2,272	1,606	1,247	1,438	1,785
Net Nonoperating Expense (NNE)	216	2,613	136	-24	41	2,149	-139	196	119	251	640
Net Nonoperating Obligations (NNO)	5,614	5,175	2,663	2,691	3,015	1,430	1,672	3,506	3,322	3,059	2,863
Total Depreciation and Amortization (D&A)	259	432	422	416	392	382	308	338	362	335	323
Debt-free, Cash-free Net Working Capital to Revenue	20.87%	17.41%	15.67%	21.22%	26.97%	28.31%	24.43%	23.40%	20.10%	20.93%	30.32%
Debt-free Net Working Capital to Revenue	30.75%	29.20%	29.40%	32.86%	36.13%	43.76%	69.49%	36.90%	36.24%	33.71%	42.82%
Net Working Capital to Revenue	5.66%	18.35%	27.97%	28.84%	36.04%	42.84%	54.90%	36.08%	26.78%	32.87%	41.96%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.92	($28.01)	$0.84	$0.95	$1.07	($1.19)	($0.52)	($1.04)	($0.09)	($1.25)	($10.29)
Adjusted Weighted Average Basic Shares Outstanding	139.30M	143.30M	142.30M	137.80M	136M	136.10M	133.60M	134.50M	135.30M	137.40M	138.50M
Adjusted Diluted Earnings per Share	$0.92	($28.01)	$0.84	$0.95	$1.07	($1.19)	($0.52)	($1.04)	($0.09)	($1.25)	($10.29)
Adjusted Weighted Average Diluted Shares Outstanding	139.80M	143.30M	142.60M	138.30M	136.50M	136.10M	133.60M	134.50M	135.30M	137.40M	138.50M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	146.28M	143.40M	140.83M	135.87M	136.13M	133.10M	133.78M	134.65M	135.52M	136.46M	137.65M
Normalized Net Operating Profit after Tax (NOPAT)	358	464	495	337	150	188	420	85	199	218	219
Normalized NOPAT Margin	8.47%	8.78%	10.00%	7.13%	3.88%	4.60%	10.15%	1.91%	4.27%	4.99%	5.15%
Pre Tax Income Margin	6.16%	-91.81%	5.66%	6.14%	3.82%	0.14%	6.25%	-3.12%	-0.18%	-1.85%	-30.52%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	2.66	-21.27	1.92	3.26	2.26	1.04	3.07	2.90	0.00	16.99	0.00
NOPAT to Interest Expense	2.25	-6.43	0.84	0.83	1.59	13.45	-1.66	6.21	0.00	11.80	0.00
EBIT Less CapEx to Interest Expense	1.79	-21.76	1.63	2.19	-0.18	-0.35	1.85	-5.07	0.00	4.99	0.00
NOPAT Less CapEx to Interest Expense	1.37	-6.92	0.55	-0.25	-0.85	12.06	-2.88	-1.76	0.00	-0.20	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	47.61%	-2.07%	76.17%	80.08%	76.93%	-76.20%	-188.10%	-101.28%	-1,178.74%	-88.77%	-11.18%
Augmented Payout Ratio	73.84%	-2.33%	236.29%	385.42%	76.93%	-177.18%	-188.10%	-101.28%	-1,178.74%	-88.77%	-11.18%

This table displays calculated financial ratios and metrics derived from Perrigo's official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/30/2024	6/29/2024	9/28/2024	12/31/2024	3/29/2025	6/28/2025	9/27/2025	12/31/2025	3/28/2026
DEI Shares Outstanding	-	-	-	-	-	-	-	-	-	-	137,649,352.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	137,649,352.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	-2.90
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	2.15%	0.16%	-8.43%	-10.69%	-3.23%	-1.62%	-3.53%	-0.86%	-4.06%	-2.52%	-7.16%
EBITDA Growth	21.24%	-43.16%	-80.93%	-67.54%	8.50%	183.78%	393.89%	151.05%	-24.77%	-755.33%	-332.28%
EBIT Growth	69.00%	-156.02%	-215.83%	-144.96%	34.77%	870.47%	185.07%	243.14%	-25.44%	-1,222.39%	-874.42%
NOPAT Growth	114.97%	-150.00%	-211.44%	-182.56%	-230.32%	-523.11%	101.46%	61.76%	163.41%	-1,232.64%	-46,220.75%
Net Income Growth	128.74%	-36.29%	166.67%	-1,390.48%	-247.89%	-37.46%	-420.00%	92.25%	135.71%	-3,093.92%	-6,128.13%
EPS Growth	127.03%	-35.29%	150.00%	-1,416.67%	-250.00%	-39.13%	-600.00%	92.41%	133.33%	-3,096.88%	-5,640.00%
Operating Cash Flow Growth	110.30%	12.26%	-107.22%	-82.04%	-66.10%	49.78%	-4,507.14%	698.95%	22.51%	-43.89%	-76.12%
Free Cash Flow Firm Growth	104.41%	116.45%	114.35%	373.32%	353.87%	160.45%	112.43%	-74.14%	53.36%	5.55%	232.48%
Invested Capital Growth	-0.23%	-3.09%	-3.44%	-6.78%	-4.56%	-8.79%	-6.55%	-1.91%	-5.54%	-21.42%	-26.78%
Revenue Q/Q Growth	-5.81%	2.95%	-6.47%	-1.53%	2.06%	4.67%	-8.29%	1.19%	-1.23%	6.35%	-12.65%
EBITDA Q/Q Growth	-4.35%	-53.60%	-63.36%	99.62%	219.69%	21.35%	-36.22%	1.47%	0.84%	-1,010.73%	76.31%
EBIT Q/Q Growth	-5.71%	-123.76%	-273.15%	46.22%	382.61%	35.86%	-58.80%	-9.51%	47.20%	-2,145.24%	71.57%
NOPAT Q/Q Growth	121.69%	-121.78%	-256.13%	51.99%	-249.92%	-4.16%	100.84%	-1,355.40%	680.25%	-2,288.86%	71.07%
Net Income Q/Q Growth	69.05%	-327.46%	106.19%	-5,520.00%	80.63%	-111.43%	85.59%	-31.25%	189.29%	-19,008.00%	71.89%
EPS Q/Q Growth	66.67%	-330.00%	104.35%	-8,000.00%	81.01%	-113.33%	84.38%	-20.00%	183.33%	-20,560.00%	71.95%
Operating Cash Flow Q/Q Growth	135.35%	67.63%	-100.67%	778.57%	344.21%	640.76%	-120.63%	217.67%	-31.88%	239.27%	-164.77%
Free Cash Flow Firm Q/Q Growth	-41.11%	261.28%	1.10%	120.06%	-43.53%	107.32%	-17.54%	-73.21%	234.84%	42.69%	159.73%
Invested Capital Q/Q Growth	-1.92%	-1.66%	0.05%	-3.39%	0.41%	-6.02%	2.51%	1.40%	-3.31%	-21.81%	-4.48%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	36.59%	36.94%	33.06%	37.04%	37.19%	33.90%	37.58%	34.36%	36.14%	32.64%	33.58%
EBITDA Margin	13.71%	6.18%	2.42%	4.91%	15.37%	17.82%	12.40%	12.43%	12.69%	-108.67%	-29.48%
Operating Margin	5.53%	-1.34%	-5.10%	-2.49%	7.39%	10.03%	4.49%	4.30%	6.96%	-116.00%	-38.41%
EBIT Margin	5.58%	-1.29%	-5.14%	-2.81%	7.77%	10.09%	4.53%	4.05%	6.04%	-116.12%	-37.79%
Profit (Net Income) Margin	1.26%	-2.79%	0.18%	-10.17%	-1.93%	-3.90%	-0.61%	-0.80%	0.72%	-127.80%	-41.13%
Tax Burden Percent	73.96%	59.48%	-2.03%	146.49%	-96.33%	-63.34%	-77.11%	-262.50%	33.48%	106.48%	97.58%
Interest Burden Percent	30.62%	364.43%	177.34%	247.49%	25.80%	61.06%	17.55%	7.48%	35.56%	103.36%	111.52%
Effective Tax Rate	19.79%	0.00%	0.00%	0.00%	180.73%	159.20%	98.80%	115.63%	43.30%	0.00%	0.00%
Return on Invested Capital (ROIC)	2.50%	-0.53%	-1.97%	-0.95%	-3.26%	-3.36%	0.03%	-0.38%	2.21%	-52.42%	-17.15%
ROIC Less NNEP Spread (ROIC-NNEP)	1.51%	-1.16%	-0.81%	-3.59%	-1.96%	-2.63%	-0.18%	-0.42%	1.14%	-69.88%	-21.57%
Return on Net Nonoperating Assets (RNNOA)	1.15%	-0.82%	-0.59%	-2.60%	-1.43%	-1.85%	-0.13%	-0.30%	0.79%	-57.04%	-19.61%
Return on Equity (ROE)	3.65%	-1.36%	-2.56%	-3.55%	-4.69%	-5.21%	-0.10%	-0.67%	3.00%	-109.46%	-36.76%
Cash Return on Invested Capital (CROIC)	1.03%	4.43%	3.91%	6.71%	4.52%	10.22%	-10.49%	-0.20%	4.67%	12.06%	14.45%
Operating Return on Assets (OROA)	2.42%	-0.55%	-2.17%	-1.16%	3.11%	4.31%	1.93%	1.71%	2.43%	-54.32%	-17.80%
Return on Assets (ROA)	0.55%	-1.19%	0.08%	-4.22%	-0.77%	-1.67%	-0.26%	-0.34%	0.29%	-59.79%	-19.37%
Return on Common Equity (ROCE)	3.65%	-1.36%	-2.56%	-3.55%	-4.69%	-5.21%	-0.10%	-0.67%	3.00%	-109.46%	-36.76%
Return on Equity Simple (ROE_SIMPLE)	-0.09%	0.00%	-0.16%	-2.74%	-3.50%	0.00%	-4.13%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	50	-11	-39	-19	-65	-68	0.57	-7.09	41	-901	-261
NOPAT Margin	4.43%	-0.94%	-3.57%	-1.74%	-5.97%	-5.94%	0.05%	-0.67%	3.95%	-81.20%	-26.89%
Net Nonoperating Expense Percent (NNEP)	1.00%	0.63%	-1.17%	2.64%	-1.30%	-0.73%	0.21%	0.04%	1.08%	17.46%	4.42%
Return On Investment Capital (ROIC_SIMPLE)	0.56%	-0.12%	-0.44%	-0.22%	-0.70%	-0.85%	0.01%	-0.09%	0.51%	-13.70%	-4.25%
Cost of Revenue to Revenue	63.41%	63.06%	66.94%	62.96%	62.81%	66.10%	62.42%	65.64%	63.86%	67.36%	66.42%
SG&A Expenses to Revenue	11.21%	11.12%	12.05%	11.83%	10.75%	8.31%	10.75%	10.70%	9.03%	10.50%	11.87%
R&D to Revenue	2.63%	2.56%	2.68%	2.76%	2.39%	2.44%	2.56%	2.08%	2.39%	1.96%	2.54%
Operating Expenses to Revenue	31.06%	38.28%	38.16%	39.53%	29.79%	23.87%	33.09%	30.06%	29.19%	148.64%	72.00%
Earnings before Interest and Taxes (EBIT)	63	-15	-56	-30	85	115	47	43	63	-1,289	-366
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	154	72	26	52	167	203	129	131	132	-1,206	-286
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.86	0.87	0.89	0.74	0.74	0.79	0.87	0.79	0.65	0.64	0.51
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.87	0.89	0.91	0.76	0.77	0.78	0.87	0.82	0.67	0.44	0.31
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	3.58%	3.56%	3.54%	4.40%	4.38%	4.34%	3.98%	4.32%	5.34%	8.33%	12.17%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.92	0.92	0.94	0.88	0.85	0.88	0.92	0.88	0.82	0.86	0.82
Enterprise Value to Revenue (EV/Rev)	1.62	1.60	1.66	1.55	1.52	1.48	1.61	1.56	1.42	1.17	1.09
Enterprise Value to EBITDA (EV/EBITDA)	13.05	14.21	18.34	22.60	21.05	14.46	12.68	10.66	10.39	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	37.03	45.88	129.02	0.00	0.00	56.99	32.28	23.25	22.77	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	113.75	70.03	224.47	0.00	0.00	82.07	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	19.72	18.36	19.69	20.14	25.77	17.87	23.33	18.37	16.24	20.89	24.07
Enterprise Value to Free Cash Flow (EV/FCFF)	88.84	20.44	23.50	12.64	18.36	8.21	0.00	0.00	17.11	6.27	4.82
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.86	0.85	0.87	0.89	1.04	0.84	0.83	0.82	0.82	1.24	1.45
Long-Term Debt to Equity	0.85	0.76	0.77	0.80	0.94	0.83	0.82	0.81	0.81	1.23	1.45
Financial Leverage	0.76	0.71	0.73	0.73	0.73	0.70	0.73	0.72	0.69	0.82	0.91
Leverage Ratio	2.29	2.27	2.27	2.27	2.36	2.25	2.25	2.27	2.36	2.51	2.59
Compound Leverage Factor	0.70	8.28	4.02	5.63	0.61	1.37	0.40	0.17	0.84	2.59	2.88
Debt to Total Capital	46.31%	46.07%	46.45%	47.17%	51.00%	45.58%	45.39%	44.95%	45.05%	55.36%	59.25%
Short-Term Debt to Total Capital	0.43%	4.98%	5.03%	5.12%	4.73%	0.46%	0.45%	0.45%	0.45%	0.56%	0.19%
Long-Term Debt to Total Capital	45.88%	41.09%	41.42%	42.04%	46.28%	45.12%	44.94%	44.50%	44.59%	54.80%	59.06%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	53.69%	53.93%	53.55%	52.83%	49.00%	54.42%	54.61%	55.05%	54.95%	44.64%	40.75%
Debt to EBITDA	7.07	7.77	9.85	13.34	14.99	8.07	6.57	5.79	6.21	-4.48	-2.97
Net Debt to EBITDA	6.03	6.34	8.25	11.56	10.37	6.82	5.83	5.07	5.47	-3.83	-2.68
Long-Term Debt to EBITDA	7.00	6.93	8.78	11.89	13.60	7.98	6.51	5.73	6.14	-4.43	-2.96
Debt to NOPAT	61.60	38.31	120.50	-165.14	-404.19	45.78	-2.68	-22.12	-46.51	-4.63	-3.37
Net Debt to NOPAT	52.58	31.24	100.98	-143.05	-279.74	38.71	-2.38	-19.37	-41.00	-3.96	-3.04
Long-Term Debt to NOPAT	61.02	34.17	107.44	-147.20	-366.72	45.32	-2.66	-21.90	-46.04	-4.59	-3.36
Altman Z-Score	0.79	0.70	0.70	0.64	0.69	0.73	0.74	0.68	0.65	-0.15	0.06
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.74	1.79	1.81	1.99	2.56	2.38	2.36	2.32	2.51	2.76	2.72
Quick Ratio	1.33	0.47	0.93	0.85	1.55	0.62	1.05	1.01	0.94	1.13	1.06
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	68	247	250	550	310	644	531	142	476	679	1,765
Operating Cash Flow to CapEx	391.51%	858.85%	-5.58%	33.45%	155.72%	944.41%	-252.94%	395.31%	236.07%	654.48%	-823.19%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	5.81	0.00	60.88	0.00	0.00	0.00	0.00	0.00	1,260.49
Operating Cash Flow to Interest Expense	0.00	0.00	-0.03	0.00	8.27	0.00	0.00	0.00	0.00	0.00	-81.14
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	-0.62	0.00	2.96	0.00	0.00	0.00	0.00	0.00	-91.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.43	0.43	0.42	0.41	0.40	0.43	0.43	0.42	0.40	0.47	0.47
Accounts Receivable Turnover	6.44	6.48	6.00	5.98	5.77	6.33	5.79	6.16	5.99	6.78	5.91
Inventory Turnover	2.70	2.60	2.54	2.48	2.46	2.55	2.42	2.39	2.34	2.47	2.42
Fixed Asset Turnover	5.34	5.05	4.98	4.84	4.85	4.77	4.75	4.74	4.73	4.68	4.67
Accounts Payable Turnover	6.75	5.86	6.11	6.02	6.30	5.82	5.77	5.79	5.95	5.69	5.87
Days Sales Outstanding (DSO)	56.69	56.32	60.83	61.00	63.31	57.67	63.01	59.24	60.96	53.86	61.75
Days Inventory Outstanding (DIO)	135.12	140.54	143.44	146.89	148.40	143.30	150.63	153.04	155.90	147.58	151.03
Days Payable Outstanding (DPO)	54.09	62.26	59.69	60.59	57.95	62.72	63.26	63.04	61.30	64.15	62.17
Cash Conversion Cycle (CCC)	137.72	134.60	144.59	147.29	153.77	138.24	150.38	149.24	155.57	137.29	150.61
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	8,226	8,090	8,094	7,819	7,851	7,379	7,564	7,670	7,416	5,798	5,539
Invested Capital Turnover	0.57	0.57	0.55	0.55	0.55	0.57	0.55	0.56	0.56	0.65	0.64
Increase / (Decrease) in Invested Capital	-19	-258	-289	-568	-375	-711	-530	-149	-435	-1,580	-2,025
Enterprise Value (EV)	7,546	7,446	7,574	6,872	6,676	6,486	6,996	6,727	6,101	4,983	4,558
Market Capitalization	4,058	4,124	4,167	3,358	3,386	3,427	3,778	3,530	2,888	1,874	1,283
Book Value per Share	$34.99	$35.19	$34.31	$33.34	$33.47	$31.66	$31.98	$32.53	$32.32	$21.33	$18.15
Tangible Book Value per Share	($12.98)	($12.89)	($12.31)	($10.73)	($11.11)	($10.48)	($10.80)	($11.42)	($9.59)	($10.69)	($10.66)
Total Capital	8,825	8,841	8,753	8,603	9,319	7,938	7,992	8,124	8,091	6,576	6,131
Total Debt	4,087	4,073	4,066	4,058	4,753	3,618	3,628	3,652	3,645	3,640	3,633
Total Long-Term Debt	4,049	3,633	3,625	3,617	4,313	3,582	3,591	3,616	3,608	3,604	3,621
Net Debt	3,488	3,322	3,407	3,515	3,290	3,059	3,218	3,198	3,213	3,109	3,275
Capital Expenditures (CapEx)	32	24	25	28	27	33	26	19	22	27	14
Debt-free, Cash-free Net Working Capital (DFCFNWC)	1,197	936	1,034	1,369	1,235	915	1,086	1,071	1,338	1,290	1,369
Debt-free Net Working Capital (DFNWC)	1,795	1,687	1,693	1,912	2,698	1,474	1,495	1,525	1,771	1,821	1,726
Net Working Capital (NWC)	1,757	1,247	1,252	1,471	2,257	1,438	1,459	1,489	1,734	1,785	1,715
Net Nonoperating Expense (NNE)	36	21	-41	90	-44	-23	6.97	1.31	34	517	138
Net Nonoperating Obligations (NNO)	3,488	3,322	3,407	3,274	3,285	3,059	3,200	3,198	2,970	2,863	3,040
Total Depreciation and Amortization (D&A)	91	86	82	82	83	88	82	89	69	83	81
Debt-free, Cash-free Net Working Capital to Revenue	25.71%	20.10%	22.70%	30.91%	28.11%	20.93%	25.04%	24.76%	31.26%	30.32%	32.76%
Debt-free Net Working Capital to Revenue	38.57%	36.24%	37.15%	43.17%	61.43%	33.71%	34.49%	35.26%	41.35%	42.82%	41.31%
Net Working Capital to Revenue	37.75%	26.78%	27.48%	33.22%	51.39%	32.87%	33.66%	34.42%	40.49%	41.96%	41.04%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.10	($0.23)	$0.01	($0.79)	($0.15)	($0.32)	($0.05)	($0.06)	$0.05	($10.23)	($2.87)
Adjusted Weighted Average Basic Shares Outstanding	135.50M	135.30M	136.60M	137.10M	137.50M	137.40M	137.70M	138.20M	138.50M	138.50M	138.70M
Adjusted Diluted Earnings per Share	$0.10	($0.23)	$0.01	($0.79)	($0.15)	($0.32)	($0.05)	($0.06)	$0.05	($10.23)	($2.87)
Adjusted Weighted Average Diluted Shares Outstanding	136.90M	135.30M	137.60M	137.10M	137.50M	137.40M	137.70M	138.20M	138.90M	138.50M	138.70M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	135.51M	135.52M	136.32M	136.42M	136.43M	136.46M	137.48M	137.58M	137.62M	137.65M	138.37M
Normalized Net Operating Profit after Tax (NOPAT)	62	0.77	-7.63	31	79	88	56	39	53	59	24
Normalized NOPAT Margin	5.54%	0.07%	-0.71%	2.92%	7.30%	7.77%	5.32%	3.68%	5.08%	5.32%	2.43%
Pre Tax Income Margin	1.71%	-4.69%	-9.11%	-6.95%	2.00%	6.16%	0.80%	0.30%	2.15%	-120.03%	-42.15%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	-1.29	0.00	16.57	0.00	0.00	0.00	0.00	0.00	-261.64
NOPAT to Interest Expense	0.00	0.00	-0.90	0.00	-12.73	0.00	0.00	0.00	0.00	0.00	-186.15
EBIT Less CapEx to Interest Expense	0.00	0.00	-1.88	0.00	11.25	0.00	0.00	0.00	0.00	0.00	-271.50
NOPAT Less CapEx to Interest Expense	0.00	0.00	-1.48	0.00	-18.04	0.00	0.00	0.00	0.00	0.00	-196.01
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	-3,597.56%	-1,178.74%	-1,962.34%	-121.93%	-94.24%	-88.77%	-86.29%	-195.39%	-307.54%	-11.18%	-8.73%
Augmented Payout Ratio	-3,597.56%	-1,178.74%	-1,962.34%	-121.93%	-94.24%	-88.77%	-86.29%	-195.39%	-307.54%	-11.18%	-8.73%

Financials Breakdown Chart

Key Financial Trends

Here are the key takeaways for Perrigo (PRGO) based on the last four years of quarterly results (2022–2025), with a focus on trends in revenue, profitability, cash flow, and balance sheet quality.

Operating cash flow remains positive in the latest periods, with Net Cash From Continuing Operating Activities of about $175.4 million in Q4 2025, signaling ongoing cash generation to fund operations and shareholder activity.
Dividend per share has been maintained around the mid-$0.27 to $0.29 range, providing a steady income to shareholders (recent rate shown as $0.29 per share).
Revenue stays in a stable, scale range near $1.0B–$1.12B per quarter across the period, indicating Perrigo’s continued market presence in its OTC/consumer healthcare segment.
There are quarters of positive earnings before impairment (e.g., Q3 2025 net income of about $7.5 million), suggesting underlying profitability outside one-time charges.
Balance sheet size is solid, with Total Assets typically in the $9.7B–$10.6B range and Total Equity around $4.0B–$4.7B, providing a reasonable cushion to absorb volatility.
Goodwill and intangible assets are substantial (roughly $3.3B–$3.6B in Goodwill and related intangibles), which creates ongoing impairment risk if market conditions deteriorate or strategic priorities shift.
Operating working capital remains elevated, with Inventories around $1.0B–$1.3B and Accounts Receivable commonly in the $0.6B–$0.7B range, indicating significant capital being tied up in day-to-day operations.
A one-time impairment charge in Q4 2025 of about $1.36B dramatically reduced operating income and net income for that quarter.
Earnings volatility is evident, with multiple quarters showing negative net income and EPS (e.g., Q4 2025 Consolidated Net Income around -$1.418B; Q1–Q2 2025 also negative), highlighting earnings quality challenges outside impairment events.

05/14/26 07:37 AM ETAI Generated. May Contain Errors.

Perrigo Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Perrigo's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Perrigo's net income appears to be on a downward trend, with a most recent value of -$1.43 billion in 2025, falling from $136.10 million in 2015. The previous period was -$171.80 million in 2024. See Perrigo's forecast for analyst expectations on what's next for the company.

Perrigo's total operating income in 2025 was -$1.12 billion, based on the following breakdown:

Total Gross Profit: $1.49 billion
Total Operating Expenses: $2.62 billion

Over the last 10 years, Perrigo's total revenue changed from $4.23 billion in 2015 to $4.25 billion in 2025, a change of 0.6%.

Perrigo's total liabilities were at $5.60 billion at the end of 2025, a 5.1% increase from 2024, and a 39.4% decrease since 2015.

In the past 10 years, Perrigo's cash and equivalents has ranged from $0.00 in 2022 to $1.86 billion in 2021, and is currently $531.60 million as of their latest financial filing in 2025.

Over the last 10 years, Perrigo's book value per share changed from 69.10 in 2015 to 21.33 in 2025, a change of -69.1%.

Related Companies

Financial statements for NYSE:PRGO last updated on 5/8/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Perrigo (PRGO) Financials

Financials Breakdown Chart

Key Financial Trends

Perrigo Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Perrigo (PRGO) Financials

Annual Income Statements for Perrigo

Quarterly Income Statements for Perrigo

Annual Cash Flow Statements for Perrigo

Quarterly Cash Flow Statements for Perrigo

Annual Balance Sheets for Perrigo

Quarterly Balance Sheets for Perrigo

Annual Metrics And Ratios for Perrigo

Quarterly Metrics And Ratios for Perrigo

Financials Breakdown Chart

Key Financial Trends

Perrigo Financials - Frequently Asked Questions

When does Perrigo's fiscal year end?

How has Perrigo's net income changed over the last 10 years?

What is Perrigo's operating income?

How has Perrigo's revenue changed over the last 10 years?

How much debt does Perrigo have?

How much cash does Perrigo have?

How has Perrigo's book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools